171 related articles for article (PubMed ID: 2970009)
21. Ipratropium.
Med Lett Drugs Ther; 1987 Jul; 29(745):71-2. PubMed ID: 2885730
[No Abstract] [Full Text] [Related]
22. Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.
Simonsson BG
Scand J Respir Dis Suppl; 1979; 103():130-42. PubMed ID: 155288
[No Abstract] [Full Text] [Related]
23. Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers.
Hodges IG; Groggins RC; Milner AD; Stokes GM
Arch Dis Child; 1981 Sep; 56(9):729-32. PubMed ID: 6457571
[TBL] [Abstract][Full Text] [Related]
24. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
Verstraeten JM
Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
[No Abstract] [Full Text] [Related]
25. Use of ipratropium bromide in obstructive lung disease.
Mann KV; Leon AL; Tietze KJ
Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
[TBL] [Abstract][Full Text] [Related]
26. [Anticholinergic agents in the treatment of obstructive bronchopulmonary diseases (author's transl)].
Juricić V; Radosević Z
Plucne Bolesti Tuberk; 1978; 30(1-2):61-5. PubMed ID: 149991
[No Abstract] [Full Text] [Related]
27. The background to Duovent.
Phillips VJ
Postgrad Med J; 1984; 60 Suppl 1():13-7. PubMed ID: 6233545
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy--a review of clinical studies.
Rudolf M
Postgrad Med J; 1984; 60 Suppl 1():9-12. PubMed ID: 6145152
[TBL] [Abstract][Full Text] [Related]
29. [Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)].
Schultze-Werninghaus G; Gonsior E; Meier-Sydow J
Dtsch Med Wochenschr; 1979 Aug; 104(31):1098-104. PubMed ID: 37060
[TBL] [Abstract][Full Text] [Related]
30. A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction.
Sahay JN; Chatterjee SS; Summerfield PJ
Br J Clin Pract; 1986 May; 40(5):198-202. PubMed ID: 2944533
[No Abstract] [Full Text] [Related]
31. Ipratropium: an alternative for bronchodilator therapy.
Lynn MM; Holdcroft C
Nurse Pract; 1990 May; 15(5):44-8. PubMed ID: 2140435
[No Abstract] [Full Text] [Related]
32. Duovent--is logic enough?
Drug Ther Bull; 1985 Jan; 23(1):3-4. PubMed ID: 3155677
[No Abstract] [Full Text] [Related]
33. Ipratropium bromide in COPD and asthma.
Atsmon J
Am J Med Sci; 1988 Aug; 296(2):140-2. PubMed ID: 2969679
[No Abstract] [Full Text] [Related]
34. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
[No Abstract] [Full Text] [Related]
35. Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator.
Chervinsky P
J Allergy Clin Immunol; 1977 Jan; 59(1):22-30. PubMed ID: 137921
[TBL] [Abstract][Full Text] [Related]
36. [Clinical comparison of Atrovent and a placebo in patients with chronic obstructive lung diseases].
Lien JT
Tidsskr Nor Laegeforen; 1980 Jul; 100(19-21):1193-5. PubMed ID: 6448492
[No Abstract] [Full Text] [Related]
37. Bronchodilator therapy in chronic airflow obstruction.
Niewoehner DE; Leatherman JW
Chest; 1984 Aug; 86(2):161-2. PubMed ID: 6146498
[No Abstract] [Full Text] [Related]
38. [Ipratropine and terbutaline. A comparative study of 19 patients with chronic obstructive lung diseases].
Petersen BN; Weeke E
Ugeskr Laeger; 1979 Sep; 141(36):2439-42. PubMed ID: 160643
[No Abstract] [Full Text] [Related]
39. [Value of ipratropium (Atrovent) in the treatment of chronic obstructive lung diseases in myasthenic patients treated with anticholinesterase agents. Apropos of a case].
Robinet G; Leroyer C; Andre J; Dewitte JD; Clavier J
Rev Pneumol Clin; 1989; 45(4):161-3. PubMed ID: 2533994
[TBL] [Abstract][Full Text] [Related]
40. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
Langaker O
Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
